Monkeypox Treatment market Analysis and Trends by 2022-2035 The recent rise in the incidence of the monkeypox disease, also known as Mpox, has compelled both industry players and regional government authorities to undertake active initiatives in order to control the spread of the disease Roots Analysis is pleased to announce the publication of its recent study, titled, “Monkeypox Market: Focus on Therapeutics, Vaccines and Diagnostic Kits, 2023-2035” The study features an extensive study of the current market landscape and future opportunity for the players focused on the development of monkeypox therapeutics, vaccines and diagnostic kits. Amongst other elements, the report features:  A general introduction to monkeypox virus, along with information on signs and symptoms of the disease, history of monkeypox outbreaks and details on transmission of disease from animals to humans and humans to humans.  A detailed assessment of the current market landscape of monkeypox therapeutics / vaccines that are approved / under development, based on several relevant parameters.  A detailed assessment of the current market landscape of monkeypox diagnostic kits, based on several relevant parameters.  A product competitiveness analysis of the Mpox diagnostic kits, based on supplier power and product competitiveness.  Elaborate profiles of prominent players (shortlisted based on a proprietary criterion) engaged in monkeypox therapeutics / vaccines and diagnostic kits domain.  An analysis of the partnerships that have been inked by stakeholders engaged in this domain, during the period 2018-2022 (till October).  An in-depth analysis on various grants, received since the year 2003, by players engaged in this field.  A detailed analysis of more than 200 peer-reviewed, scientific articles related to research on monkeypox therapeutics / vaccines and diagnostic kits, during the period of 2018-2022 (till September).  A qualitative analysis to understand the five competitive forces under an insightful Porter's Five Forces framework.  A detailed market forecast for monkeypox therapeutics / vaccines and diagnostic kits, featuring analysis of the current and projected future opportunity across key market segments (listed below):  Type of Product  Therapeutics  Vaccines  Developer  Bavarian Nordic  Emergent BioSolutions  KM Biologics  SIGA Technologies  Type of Kit  Polymerase Chain Reaction (PCR) Detection Kits  Antigen Detection Kits  Antibody Detection Kits  Type of End User  Hospitals and Clinics  Diagnostic Laboratories  Other End Users  Key Geographical Regions  North America (US and Canada)  Europe (UK, France, Germany, Spain, Italy, Rest of EU)  Asia-Pacific (Japan and Australia)  Rest of the World  Transcripts of interviews held with the following senior level representatives of stakeholder companies:  Willy Tozoke Laou Man Cheong (Business Director, Hunan Runmei Gene Technology)  John W Sharkey (Vice President, Business Development, GeoVax)  Horace Lee (Sales Manager, Firegene)  Alan Yu (Sales Manager, Hangzhou Testsea Biotechnology) Key companies covered in the report  Bavarian Nordic  Emergent BioSolutions  ACON Laboratories  altona Diagnostics  DNA Software  Elabscience  Goldsite Diagnostics  Hangzhou Testsea Biotechnology  Jiangsu Bioperfectus Technologies  Lansion Biotechnology To view more details on this report, click on the link https://www.rootsanalysis.com/reports/monkeypox-treatment-market.html You may also be interested in the following titles: Decentralized Clinical Trials / Virtual Clinical Trials Market Global Antibiotics Market About Roots Analysis Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights. Contact: Ben Johnson +1 (415) 800 3415 Ben.johnson@rootsanalysis.com #MonkeypoxTreatmentMarket #MonkeypoxTreatmentMarketGrowth #Monkeypox #mpox #Monkeypoxtreatment

Bacteriophage therapeutics market Research Report by 2022, Forecast till 2035 With the ever-increasing burden of antimicrobial resistance, the focus of the research community has shifted towards the development of alternatives for the treatment of infectious diseases. One of such alternatives is bacteriophage therapeutics. The innovators suggests that the success of these therapies lies in the effectiveness of phages to target the desired bacterial strains. The financial opportunity within the bacteriophage therapeutics market has been analyzed across the following segments:  Type of Therapeutic Area  Infectious Diseases  Oncological Disorders  Other Disorders  Distribution by Route of Administration  Oral Route  Rectal Route  Intravesical Route  Topical Route  Key Geographical Regions  North America  Europe  Asia-Pacific  Latin America  Middle East and North Africa The “Bacteriophage Therapy Market, 2022-2035” report features the following companies, which we identified to be key players in this domain:  Adaptive Phage Therapeutics  ContaFect  Eliava BioPreparations  Micreos  NPO Microgen  Phagelux  Pherecydes Pharma Table of Content 1. PREFACE 2. EXECUTIVE SUMMARY 3. INTRODUCTION 4. BACTERIOPHAGE THERAPY: MARKET LANDSCAPE 5. BACTERIOPHAGE THERAPEUTICS: DEVELOPER LANDSCAPE 6. COMPANY AND DRUG PROFILES 7. CLINICAL TRIAL ANALYSIS 8. PATENT ANALYSIS 9. PUBLICATION BENCHMARKING ANALYSIS 10. ACADEMIC GRANTS ANALYSIS 11. FUNDING AND INVESTMENT ANALYSIS 12. PARTNERSHIPS AND COLLABORATIONS 13. START-UP HEALTH INDEXING 14. MARKET FORECAST AND OPPORTUNITY ANALYSIS 15. CONCLUSION 16. EXECUTIVE INSIGHTS 17. APPENDIX I: TABULATED DATA 18. APPENDIX II: LIST OF COMPANIES AND ORGANIZATIONS For additional details, please visit https://www.rootsanalysis.com/reports/bacteriophage-therapy-market.html You may also be interested in the following titles: Pharmaceutical Polymers / Medical Polymers Market Gene Switch Market You may also like to learn what our experts are sharing in Roots educational series: T-cell Immunotherapies: The Future of Modern Cancer Treatments Monkeypox: Disease Overview, Transmission and Diagnosis About Roots Analysis Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights. Contact: Ben Johnson +1 (415) 800 3415 Ben.johnson@rootsanalysis.com #Bacteriophage therapeutics market #Bacteriophagetherapeuticsmarketsize #bacteriophagephage #bacteriophagetherapy

Bacteriophage therapeutics market Trends, Analysis by 2035 The latest research report titled ‘Manufacturing Execution System Market’, published by Roots Analysis systematically explains every single component of the Manufacturing Execution System Market, assisting the readers with an in-depth analysis of this industry vertical. Besides, the report offers a brief overview of the different market segments and explicates the current market scenario with the help of a precise summary of the global market. The Manufacturing Execution System Market can be characterized by its current position, industry size, anticipated revenue, and the potential market share and volume over the forecast timeframe. Alongside the above-mentioned information, the report offers meaningful insights into the regional outlook of the global market. An all-inclusive study of the competitive backdrop of the Manufacturing Execution System Market is a significant element of the latest report. Major Highlights of the ToC: Market Dynamics: • Market Trends • Opportunities • Market Drivers • Challenges • Influence Factors Developmental Trend Analysis: • Market Trend Analysis • Market Size (Volume and Value) Methodology/Research Approach: • Research Programs/Design • Market Size Estimation • Market Breakdown and Data Triangulation • Data Source Request a sample copy of the Manufacturing Execution System Market report https://www.rootsanalysis.com/reports/manufacturing-execution-systems-market/request-sample.html Regional Bifurcation: • The latest report categorizes the Manufacturing Execution System Market into various regions across the globe, based on their market dominance and revenue share. • The report briefs about the market share data of each of the regional segments, along with the potential growth drivers of these regions. • The report includes valuable insights into the import and export trends, revenue estimation, and production and consumption rates, as well as the leading players of each region. Prominent factors influencing the competitive landscape of the global market: • The report offers an extensive analysis of the competitive landscape of the Manufacturing Execution System Market, profiling the most prominent market players. • The report includes data pertaining to the manufacturing facilities of the key industry players, along with the market shares they hold and the regions they operate in. • Furthermore, the document covers the product catalog of leading companies, product specifications and common application types, pricing models, and the gross margins set by these companies. Other significant aspects determining the global market remuneration over the projected timeline: • The Manufacturing Execution System Market report elaborates on the diverse product range, as well as the scope of product application of this particular business vertical. • The report also encompasses other vital information associated with the global market, for instance, market share, production growth rate, net profit, and application segments. • The key factors like market concentration rate, raw material processing rate, current price trends, and estimated growth prospects of the industry have also been evaluated in this report. • The report draws a precise inference of the Manufacturing Execution System Market, giving details about the marketing approach of the leading companies, their market positions, and marketing channel development. • Additionally, the report encapsulates information related to the producers, distributors, and downstream buyers involved in this industry, and briefs about the manufacturing cost structure. Get more details on the Manufacturing Execution System Market report https://www.rootsanalysis.com/reports/manufacturing-execution-systems-market.html You may also be interested in the following titles: Blockchain Technology in Healthcare Market Monkeypox Treatment Market You may also like to learn what our experts are sharing in Roots educational series: Bioavailability Enhancement Technologies Liposomes Development: Service Providers Landscape About Roots Analysis Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights. Contact: Ben Johnson +1 (415) 800 3415 Ben.johnson@rootsanalysis.com #Bacteriophagetherapymarket #Bacteriophagetherapymarketsize #phage #bacteriophagetherapy #bacteriophage

Manufacturing Execution system Market, Industry Analysis, and Forecast to 2035 Rising complexities related to huge data volumes being generated in the healthcare sector, along with the need for visibility, control and synchronization in production processes, has prompted players in the healthcare market to integrate manufacturing execution systems Roots Analysis has announced the addition of “Manufacturing Execution System Providers in Healthcare Market, 2022-2035” report to its list of offerings. The report features an extensive study of the current market landscape and the likely future potential; associated with the manufacturing execution system market in healthcare, over the next decade. To get a sample copy of the latest market report, visit https://www.rootsanalysis.com/reports/manufacturing-execution-systems-market/request-sample.html The study also includes a detailed analysis of key drivers and trends within this evolving market. Amongst other elements, the report features:  A detailed overview of the overall market landscape of manufacturing execution system providers based on several relevant parameters  An analysis of the various partnerships related to manufacturing execution system inked by players engaged in this domain.  A detailed competitiveness analysis of manufacturing execution system providers based on parameters, such as supplier power and product specifications.  Elaborate profiles of key players offering manufacturing execution system in healthcare sector.  An insightful framework depicting the implementation of several advanced tools and technologies, such as artificial intelligence, cloud computing, machine learning and internet of things (Iot) at different stages of a manufacturing process, which can assist manufacturing execution system providers in addressing existing unmet needs.  A detailed market forecast, featuring analysis of the current and projected future opportunity across key market segments (listed below)  Type of Deployment  Cloud  Corporate Datacenter  Hybrid  On Premise  Type of End User  Life science / Biotechnology Companies  Medical Device Providers  Pharmaceutical Companies  Others  Key Geographical Regions  North America  Europe  Asia  Middle East and North Africa  Latin America  Rest of the World Key companies covered in the report  Andea  Critical Manufacturing  Dassault Systèmes  GE Digital  Infor  Körber  Rockwell Automation For additional details, please visit https://www.rootsanalysis.com/reports/manufacturing-execution-systems-market.html You may also be interested in the following titles: Blockchain Technology in Healthcare Market Monkeypox Treatment Market About Roots Analysis Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights. Contact: Ben Johnson +1 (415) 800 3415 Ben.johnson@rootsanalysis.com

The global monkeypox therapeutics and vaccines market and global monkeypox diagnostic kits market is likely to grow at a healthy pace in the foreseen future, claims Roots Analysis The recent rise in the incidence of the monkeypox disease, also known as Mpox, has compelled both industry players and regional government authorities to undertake active initiatives in order to control the spread of the disease For additional details, please visit https://www.rootsanalysis.com/reports/monkeypox-treatment-market.html

RNA Therapeutics Market Growth Opportunity and Industry Forecast to 2035 The new market report titled ‘RNA Therapeutics Market,’ published by Roots Analysis is one of the most sought-after solutions for businesses operating in the RNA Therapeutics Market. The report will help readers stay updated with the latest market trends and maintain their competitive outlooks in the modern-day fast-paced business environment. The report comes with a concise summary of the details regarding the historical market data, current market trends, future growth prospects, product landscape, key marketing strategies, technological progress, as well as the emerging market trends and opportunities. The RNA Therapeutics Market is anticipated to expand significantly. However, the latest report is mainly intended for readers interested in this specific business space and is available in the forms of PDF and spreadsheet. To understand the complete structure of the report, get its PDF sample copy https://www.rootsanalysis.com/reports/opportunities-in-rna-therapeutics-market/request-sample.html RNA Therapeutics Market Characterization: Market Scope and Market Size: The RNA Therapeutics market is broadly segmented on the basis of product type and application. The segmental growth helps the reader get a lucid picture of the niche pockets of growth, as well as the strategies deployed by the market players to drive the growth of these segments. This section of the report helps them understand and determine the core application areas and the differences between the target markets. The report scrutinizes the RNA Therapeutics market in terms of market size & volume and significant information pertaining to product bifurcation and application overview. Key Market Contenders: This particular section of the report covers all the necessary details of the renowned market players operating in the RNA Therapeutics market. The report goes on to elucidate various marketing strategies employed by companies across this industry. Information on the shareholdings of these players in the global market has also been included in this report. Moreover, the document presents a detailed account of the market size based on geographical segmentation. It also covers the product portfolio, their application landscape, and sales and revenue predictions of the regional fragments of the global market. The section of this report focusing on the competitive terrain of the RNA Therapeutics market endows the reader with every significant detail and information about the leading competitors on the market. The report provides an exhaustive study and accurate statistics on revenue (on both global and regional levels) related to the prevalent competition in the market. The report offers additional details on this fundamental market segment, including major businesses, company description, total revenue & sales, recent developments, latest product launches, and revenue accumulated by these players over the forecast period. Main chapters covered in this report: Part 01: Market Overview Part 02: Market Size, by regions Part 03: Market Revenue, by countries Part 04: Market Competition, by key players Part 05: Company Profiles To view more details on this report, click on the link: https://www.rootsanalysis.com/reports/opportunities-in-rna-therapeutics-market.html You may also be interested in the following titles: Microbiome Therapeutics Rare Kidney Diseases Market You may also like to learn what our experts are sharing in Roots educational series: Monkeypox: Disease Overview, Transmission and Diagnosis Antiviral Drugs Development: Are we Prepared for the Next Viral Pandemic? About Roots Analysis Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights. Contact: Ben Johnson +1 (415) 800 3415 Ben.johnson@rootsanalysis.com #RNATherapeuticsMarketTrends #RNATherapeuticsIndustryAnalysis #RNATherapeuticsMarketForecast #RNATherapeuticsMarketGrowthAnalysis

Monkeypox: Disease Overview, Transmission and Diagnosis Monkeypox is a viral disease, which is usually transmitted to humans from animals. The disease is known to have symptoms similar to those observed in smallpox patients, although it is considered to be clinically less severe. In recent years, monkey pox has emerged as a prominent orthopox virus affecting public health. In May 2022, multiple cases of the disease were reported in more than 100 non-endemic countries, thereby making monkeypox a disease of global concern. Consequently, in July 2022, the World Health Organization (WHO) declared global monkey pox outbreak a Public Health Emergency of International Concern (PHEIC). In fact, till date, over 84,000 cases of the disease have been reported, globally. Monkeypox infection can be divided into two periods: 1. Invasion Period (0 to 5 days): This phase is characterized by fever, intense headache, lymphadenopathy (swelling of the lymph nodes), back pain, myalgia (muscle aches) and intense asthenia (lack of energy) 2. Skin Eruption (begins within 1 to 3 days of appearance of fever): Monkeypox rash affects the face (in 95% of cases), palms of the hands and soles of the feet (in 75% of cases). Oral mucous membranes (in 70% of cases), genitalia (30%), and conjunctivae (20%), as well as the cornea are also affected. Monkeypox Disease Transmission Monkeypox virus can be transmitted from animals to humans as well as from humans to humans.  Animals to Humans Transmission: Zootnotic transmission can occur from direct contact with the bodily fluids, blood or cutaneous / mucosal lesions of infected animals. Additionally, eating inadequately cooked meat and other animal products of infected animals is a possible risk factor.  Humans to Humans Transmission: Human-to-human transmission can result from close contact with respiratory secretions, skin lesions of an infected person or recently contaminated objects. Transmission can also occur via the placenta from mother to fetus or during close contact during and after birth. Monkeypox Disease Diagnosis Polymerase chain reaction (PCR) is the preferred laboratory test for monkey pox virus detection due to its accuracy and sensitivity. Optimal diagnostic samples for monkey pox diagnosis are collected from skin lesions; these include roof or fluid from vesicles and pustules, and dry crusts. Additionally, biopsy samples can also be collected for disease diagnosis. Conclusion With only a few therapeutics / vaccines currently approved or granted special access for the monkeypox treatment / prevention, the existing demand for effective monkeypox vaccines and therapeutics is still unmet. In response to the monkey pox outbreak, active research and development efforts are underway to develop various therapeutics and vaccines for the treatment and prevention of monkeypox. Presently, more than 25 therapeutics / vaccines are commercialized / under development for the treatment and prevention of monkeypox. With the increase in the number of monkeypox cases globally, the demand for testing has also increased. At present, more than 165 diagnostic kits are available in the market for the detection of monkeypox virus. The growing cases of monkeypox disease and availability of limited number of therapeutics / vaccines / diagnostic solutions are the key factors driving the growth of this market. For additional details, please visit https://www.rootsanalysis.com/blog/monkeypox-disease-overview/ or email sales@rootsanalysis.com You may also be interested in the following titles: 1. Smart Labels Market: Industry Trends and Global Forecasts, 2022-2035 2. AI-based Digital Pathology / AI Pathology Market: Industry Trends and Global Forecasts, 2022-2035 About Roots Analysis Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights. Contact: Ben Johnson +1 (415) 800 3415 Ben.johnson@rootsanalysis.com